$2.05
-0.06-2.84%
In chiusura: Sep 11, 5:00 PM EST
$2.17
0.125.76%
Post-mercato: Sep 11, 6:46 PM EST

Elicio Therapeutics (ELTX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.54 | $-0.47 | $-0.46 | $-0.54 |
| Actual | $-0.43 | $-0.65 | $-0.45 | $-0.60 |
| Surprise | +20.4% | -38.3% | +2.17% | -11.1% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.46 | $-0.45 | $-0.48 | $-0.59 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.43 | $-0.54 | 20.4 % |
| Q1 | May 11, 2026 | $-0.65 | $-0.47 | -38.3 % |
| Q4 | Mar 12, 2026 | $-0.45 | $-0.46 | 2.17 % |
| Q3 | Nov 13, 2025 | $-0.60 | $-0.54 | -11.1 % |